ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
96.55
-4.32 (-4.28%)
At close: Jun 12, 2026, 4:00 PM EDT
98.02
+1.47 (1.52%)
After-hours: Jun 12, 2026, 7:41 PM EDT
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of $7.85 billion as of June 12, 2026. Its market cap has increased by 1,425.10% in one year.
Market Cap
7.85B
Enterprise Value
7.32B
1-Year Change
1,425.10%
Ranking
Category
Stock Price
$96.55
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from $225.47M to $7.85B, an increase of 3,380.57%. That is a compound annual growth rate of 38.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 7.85B | -28.67% |
| Dec 31, 2025 | 11.00B | 2,382.10% |
| Dec 31, 2024 | 443.27M | -34.81% |
| Dec 29, 2023 | 679.99M | 513.79% |
| Dec 30, 2022 | 110.78M | -79.15% |
| Dec 31, 2021 | 531.29M | -8.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corcept Therapeutics | 8.90B |
| Bio-Techne | 8.45B |
| Halozyme Therapeutics | 8.24B |
| ImmunityBio | 7.44B |
| Praxis Precision Medicines | 7.43B |
| Kymera Therapeutics | 7.09B |
| Protagonist Therapeutics | 7.06B |
| TG Therapeutics | 7.02B |